ALVR
Allovir, Inc.
Gilead Sciences, Inc. bought $11.0M of Allovir, Inc.
10% owner
Bought$10,990,763
$3.75Price
2,930,870Shares
+21%Stake
What ALVR did for a copier
- $1,000 copied at Thu, Jun 29 open, $83.72
- $799
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Aug 11 close.
Gilead Sciences, Inc.'s record
6 other buys with 3 months of prices since 2024: on average −28.7% against the S&P 500, and 0 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jun 27. Filed Wed, Jun 28, 5:17 PM ET, after the close. Returns use the Jun 29 open and the Aug 11 close. Not investment advice.